The effect of preclinical Alzheimer's disease on age-related changes in intelligence in cognitively normal older adults

[1]  C. Jack,et al.  NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.

[2]  A. Woods,et al.  Discrepancies between crystallized and fluid ability are associated with frequency of social and physical engagement in community dwelling older adults , 2018, Journal of clinical and experimental neuropsychology.

[3]  H. Holling,et al.  Retest effects in cognitive ability tests: A meta-analysis , 2018 .

[4]  Prashanthi Vemuri,et al.  Age, vascular health, and Alzheimer disease biomarkers in an elderly sample , 2017, Annals of neurology.

[5]  Timothy J. Hohman,et al.  Evaluating Alzheimer's disease biomarkers as mediators of age-related cognitive decline , 2017, Neurobiology of Aging.

[6]  Joanne S. Robertson,et al.  Amyloid β–associated cognitive decline in the absence of clinical disease progression and systemic illness , 2017, Alzheimer's & dementia.

[7]  Joanne S. Robertson,et al.  Using Robust Normative Data to Investigate the Neuropsychology of Cognitive Aging , 2017, Archives of Clinical Neuropsychology.

[8]  P. Snyder,et al.  Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis , 2016, Alzheimer's & dementia.

[9]  Ian M. McDonough,et al.  Discrepancies between fluid and crystallized ability in healthy adults: a behavioral marker of preclinical Alzheimer's disease , 2016, Neurobiology of Aging.

[10]  Chengjie Xiong,et al.  Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age. , 2015, JAMA neurology.

[11]  Shannon M. Sisco,et al.  Predictors of Retest Effects in a Longitudinal Study of Cognitive Aging in a Diverse Community-Based Sample , 2015, Journal of the International Neuropsychological Society.

[12]  Stephen R. Aichele,et al.  Life span decrements in fluid intelligence and processing speed predict mortality risk. , 2015, Psychology and aging.

[13]  Susana Muñoz Maniega,et al.  Coupled Changes in Brain White Matter Microstructure and Fluid Intelligence in Later Life , 2015, The Journal of Neuroscience.

[14]  D. Y. Lee,et al.  Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. , 2015, JAMA.

[15]  U. Lindenberger.  Human cognitive aging: Corriger la fortune? , 2014, Science.

[16]  C. Jack,et al.  Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50–89 years: a cross-sectional study , 2014, The Lancet Neurology.

[17]  D. Bates,et al.  Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.

[18]  Rebecca A Betensky,et al.  Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease , 2014, Neurology.

[19]  S. Leurgans,et al.  Disentangling the effects of age and APOE on neuropathology and late life cognitive decline , 2014, Neurobiology of Aging.

[20]  Pierrick Bourgeat,et al.  En Attendant Centiloid , 2014 .

[21]  C. Rowe,et al.  Predicting Alzheimer disease with β‐amyloid imaging: Results from the Australian imaging, biomarkers, and lifestyle study of ageing , 2013, Annals of neurology.

[22]  C. Harada,et al.  Normal cognitive aging. , 2013, Clinics in geriatric medicine.

[23]  Paul Maruff,et al.  The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI , 2013, International Psychogeriatrics.

[24]  O. Almkvist,et al.  The effect of age on fluid intelligence is fully mediated by physical health. , 2013, Archives of gerontology and geriatrics.

[25]  T. Hedden,et al.  Meta-analysis of amyloid-cognition relations in cognitively normal older adults , 2013, Neurology.

[26]  C. Rowe,et al.  Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study , 2013, The Lancet Neurology.

[27]  Paul Maruff,et al.  Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study , 2012, Journal of clinical and experimental neuropsychology.

[28]  Henrik Zetterberg,et al.  Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. , 2012, Archives of general psychiatry.

[29]  Philip S. Insel,et al.  CSF biomarker and PIB-PET–derived beta-amyloid signature predicts metabolic, grey matter and cognitive changes in nondemented subjects , 2011, Alzheimer's & Dementia.

[30]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[31]  J. Morris,et al.  Alzheimer’s Disease: The Challenge of the Second Century , 2011, Science Translational Medicine.

[32]  R. Mayeux,et al.  Epidemiology of Alzheimer disease , 2011, Nature Reviews Neurology.

[33]  T. Salthouse.  Selective review of cognitive aging , 2010, Journal of the International Neuropsychological Society.

[34]  C. Rowe,et al.  Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging , 2010, Neurobiology of Aging.

[35]  C. Jack,et al.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.

[36]  A. Fagan,et al.  Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease , 2009, EMBO molecular medicine.

[37]  W. Mittenberg,et al.  Changes in intellectual functioning associated with normal aging. , 2009, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[38]  C. Rowe,et al.  The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease , 2009, International Psychogeriatrics.

[39]  I. Deary,et al.  Age-related Changes in Memory and Fluid Reasoning in a Sample of Healthy Old People , 2009, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition.

[40]  R. de Raedt,et al.  Differentiation Between Dementia and Depression Among Older Persons: Can the Difference Between Actual and Premorbid Intelligence Be Useful? , 2008, Journal of geriatric psychiatry and neurology.

[41]  R. Lipton,et al.  Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease , 2008, Journal of the International Neuropsychological Society.

[42]  W. Burns,et al.  Discrepancies between Premorbid and Current IQ as a Function of Progressive Mental Deterioration , 2005, Perceptual and motor skills.

[43]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[44]  Enrico Simonotto,et al.  The functional anatomy of inspection time: an event-related fMRI study , 2004, NeuroImage.

[45]  Wolfgang Prinz,et al.  Transformations in the Couplings Among Intellectual Abilities and Constituent Cognitive Processes Across the Life Span , 2004, Psychological science.

[46]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[47]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[48]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[49]  L. Cronbach,et al.  How we should measure "change": Or should we? , 1970 .

[50]  Ninoslav Mimica,et al.  Dementia: a public health priority , 2019 .

[51]  C. Rowe,et al.  Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals. , 2017, Journal of Alzheimer's disease : JAD.

[52]  F. Craik,et al.  50 Years of Cognitive Aging Theory. , 2016, The journals of gerontology. Series B, Psychological sciences and social sciences.

[53]  P. Sachdev,et al.  Influence of population versus convenience sampling on sample characteristics in studies of cognitive aging. , 2014, Annals of epidemiology.

[54]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[55]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup , 2011 .

[56]  O. Almkvist,et al.  Cognitive decline from estimated premorbid status predicts neurodegeneration in Alzheimer's disease. , 2009, Neuropsychology.

[57]  J. J. Ryan,et al.  Wechsler Adult Intelligence Scale-III , 2001 .

[58]  O. Spreen,et al.  A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary , 1991 .

[59]  R. Cattell,et al.  Age differences in fluid and crystallized intelligence. , 1967, Acta psychologica.